Apalutamide is indicated:
• in adult men for the treatment of non-metastatic castration-resistant prostate cancer (nmCRPC) who are at high risk of developing metastatic disease.
• in adult men for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC) in combination with androgen deprivation therapy (ADT).
Crohn’s disease
Guselkumab is indicated for the treatment of adult patients with moderately to severely active Crohn’s disease who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic treatment.
Ulcerative colitis
Guselkumab is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response, or were intolerant to either conventional therapy, a biologic treatment, or a Janus kinase (JAK) inhibitor.
Treatment of erectile dysfunction in adult males.
In order for tadalafil to be effective for the treatment of erectile dysfunction, sexual stimulation is required.
5 mg only: Treatment of the signs and symptoms of benign prostatic hyperplasia in adult males.
Tadaspi is not indicated for use by women
The treatment and prevention of vitamin D deficiency. As an adjunct to specific therapy for osteoporosis in patients with vitamin D deficiency. Cholecalciferol tablets are indicated for use in adults, the elderly and adolescents.
Atenolol is indicated in the treatment of:
• Management of hypertension.
• Management of angina pectoris.
• Management of cardiac arrhythmias.
• Management of myocardial infarction. Early intervention in the acute phase.
Atenolol is indicated in the treatment of:
• Management of hypertension.
• Management of angina pectoris.
• Management of cardiac arrhythmias.
• Management of myocardial infarction. Early intervention in the acute phase.
Multiple Sclerosis (MS)
It is indicated as single disease modifying therapy in adults with highly active relapsing
remitting multiple sclerosis (RRMS) for the following patient groups:
• Patients with highly active disease despite a full and adequate course of treatment with at least
disease modifying therapy (DMT).
Or
• Patients with rapidly evolving severe RRMS defined by 2 or more disabling relapses in
year, and with 1 or more Gadolinium enhancing lesions on brain Magnetic Resonance Imaging
(MRI) or a significant increase in T2 lesion load as compared to a previous recent MRI.
Treatment of erectile dysfunction in adult males.
In order for tadalafil to be effective for the treatment of erectile dysfunction, sexual stimulation is required.
5 mg only: Treatment of the signs and symptoms of benign prostatic hyperplasia in adult males.
Tadaspi is not indicated for use by women
Deferasirox is indicated for the treatment of chronic iron overload due to frequentblood transfusions (≥7 ml/kg/month of packed red blood cells) in patients with betathalassemia major aged 6 years and older.
Deferasirox is also indicated for the treatment of chronic iron overload due to bloodtransfusions when deferoxamine therapy is contraindicated or inadequate in the followingpatient groups:
-in pediatric patients with beta thalassemia major with iron overload due tofrequent blood transfusions (≥7 ml/kg/month of packed red blood cells) aged 2 to 5 years
Deferasirox is indicated for the treatment of chronic iron overload due to frequentblood transfusions (≥7 ml/kg/month of packed red blood cells) in patients with betathalassemia major aged 6 years and older.
Deferasirox is also indicated for the treatment of chronic iron overload due to bloodtransfusions when deferoxamine therapy is contraindicated or inadequate in the followingpatient groups:
-in pediatric patients with beta thalassemia major with iron overload due tofrequent blood transfusions (≥7 ml/kg/month of packed red blood cells) aged 2 to 5 years
